                         SEQUENCE LISTING

<110>  ANTHERA PHARMACEUTICALS, INC.
       MARTIN, Renee
       PENNINGTON, James
       HISLOP, Colin
       OLSON, Charles
 
<120>  METHODS OF TREATING IgA NEPHROPATHY AND HENOCH-SCHONLEIN PUPURA 
       NEPHRITIS USING A B-CELL ACTIVATING FACTOR (BAFF) INHIBITOR

<130>  059385-8100.WO00

<140>  PCT/US17/39141
<141>  2017-06-23

<150>  US 62/354,576
<151>  2016-06-24

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  291
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Gly Cys Lys Trp Asp Leu Leu Ile Lys Gln Trp Val Cys Asp Pro 
1               5                   10                  15      


Leu Gly Ser Gly Ser Ala Thr Gly Gly Ser Gly Ser Thr Ala Ser Ser 
            20                  25                  30          


Gly Ser Gly Ser Ala Thr His Met Leu Pro Gly Cys Lys Trp Asp Leu 
        35                  40                  45              


Leu Ile Lys Gln Trp Val Cys Asp Pro Leu Gly Gly Gly Gly Gly Val 
    50                  55                  60                  


Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly 
65                  70                  75                  80  


Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met 
                85                  90                  95      


Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His 
            100                 105                 110         


Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val 
        115                 120                 125             


His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr 
    130                 135                 140                 


Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly 
145                 150                 155                 160 


Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile 
                165                 170                 175     


Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val 
            180                 185                 190         


Tyr Thr Leu Pro Pro Ser Arg Asp Glu Leu Thr Lys Asn Gln Val Ser 
        195                 200                 205             


Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu 
    210                 215                 220                 


Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro 
225                 230                 235                 240 


Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val 
                245                 250                 255     


Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met 
            260                 265                 270         


His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser 
        275                 280                 285             


Pro Gly Lys 
    290     


